Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Honar Cherif

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Ejhaem|August 21, 2023
Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trialPedro Marques Ramos, Jeea Choi, Catarina D Campbell, et al.
Molecular Cancer|January 31, 2023
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advancesKarama Makni Maalej, Maysaloun Merhi, Varghese P Inchakalody, et al.
Cancer Reports (Hoboken, N.J.)|July 5, 2024
Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomesHesham Elsabah, Rola Ghasoub, Dina S Soliman, et al.
Biomedicines|March 28, 2026
BRAF Mutations in Myeloid Neoplasms: Prevalence, Co-Mutation Landscape, and Clinical Outcomes-A Comprehensive ReviewShehab F Mohamed, Ali Mohamed, Mohamed Fawzi Mudarres, et al.
Health Science Reports|June 15, 2026
Maternal and Neonatal Outcomes of Immune Thrombocytopenia in Pregnancy: A Five-Year Single-Center Cross-Sectional StudySara Elkorashi, Hassan Magboul, Abdulrahman F Al-Mashdali, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2020
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational studyChristina Zhukovsky, Sofia Sandgren, Thomas Silfverberg, et al.
Oncology|July 3, 2026
Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from QatarRola Ghasoub, Hesham Elsabah, Anas Hamad, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 10, 2025
High-Risk Bleeding in Acute Myeloid Leukemia: Clinical Presentation, Laboratory Markers, and Mortality TrendsMohammed Abdulgayoom, Yousef Al-Asa'd, Ahmed Ali, et al.
Cancer Reports (Hoboken, N.J.)|December 12, 2023
Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working GroupFeras Alfraih, Ahmed Absi, Mohamed Abuhaleeqa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancerSören Lehmann, Vladimir J N Bykov, Dina Ali, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Ejhaem|August 21, 2023
Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trialPedro Marques Ramos, Jeea Choi, Catarina D Campbell, et al.
Molecular Cancer|January 31, 2023
CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advancesKarama Makni Maalej, Maysaloun Merhi, Varghese P Inchakalody, et al.
Cancer Reports (Hoboken, N.J.)|July 5, 2024
Skull base plasmacytoma in young patients aged below 40 years: Radiological perspectives and clinical outcomesHesham Elsabah, Rola Ghasoub, Dina S Soliman, et al.
Biomedicines|March 28, 2026
BRAF Mutations in Myeloid Neoplasms: Prevalence, Co-Mutation Landscape, and Clinical Outcomes-A Comprehensive ReviewShehab F Mohamed, Ali Mohamed, Mohamed Fawzi Mudarres, et al.
Health Science Reports|June 15, 2026
Maternal and Neonatal Outcomes of Immune Thrombocytopenia in Pregnancy: A Five-Year Single-Center Cross-Sectional StudySara Elkorashi, Hassan Magboul, Abdulrahman F Al-Mashdali, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 27, 2020
Autologous haematopoietic stem cell transplantation compared with alemtuzumab for relapsing-remitting multiple sclerosis: an observational studyChristina Zhukovsky, Sofia Sandgren, Thomas Silfverberg, et al.
Oncology|July 3, 2026
Real-World Outcomes in Acute Promyelocytic Leukemia: A 13-Year Cohort from QatarRola Ghasoub, Hesham Elsabah, Anas Hamad, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|December 10, 2025
High-Risk Bleeding in Acute Myeloid Leukemia: Clinical Presentation, Laboratory Markers, and Mortality TrendsMohammed Abdulgayoom, Yousef Al-Asa'd, Ahmed Ali, et al.
Cancer Reports (Hoboken, N.J.)|December 12, 2023
Management of adult acute lymphoblastic leukemia in the Gulf Cooperation Council (GCC) countries: A consensus report from the GCC Adult ALL Working GroupFeras Alfraih, Ahmed Absi, Mohamed Abuhaleeqa, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancerSören Lehmann, Vladimir J N Bykov, Dina Ali, et al.
Pageof 6